Effectiveness of Point of Care Complete Blood Cell Count Analyzer in Reducing Time to Results
NCT ID: NCT04769336
Last Updated: 2021-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-04-01
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function Tests
NCT05457543
Evaluation of a Device That Separates Blood Cells From Serum/Plasma
NCT02853448
Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick
NCT00339911
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw
NCT01834612
Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population
NCT04889937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient
Each patient will undergo simultaneous testing with two different CBC analyzers.
Central Lab based CBC
lab samples will be sent to the central lab for CBC analysis
Point of Care CBC
lab samples will be analyzed at point of care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Central Lab based CBC
lab samples will be sent to the central lab for CBC analysis
Point of Care CBC
lab samples will be analyzed at point of care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
10 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrew Gostine, MD
Anesthesiologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern Lake Forest Hospital
Lake Forest, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-009-LFH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.